Role of myotonic dystrophy protein kinase (DMPK) in glucose homeostasis and muscle insulin action

Esther Llagostera, Daniele Catalucci, Luc Marti, Marc Liesa, Marta Camps, Theodore P. Ciaraldi, Richard Kondo, Sita Reddy, Wolfgang H. Dillmann, Manuel Palacin, Antonio Zorzano, Pilar Ruiz-Lozano, Ramon Gomis, Perla Kaliman

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Myotonic dystrophy 1 (DM1) is caused by a CTG expansion in the 3′-unstranslated region of the DMPK gene, which encodes a serine/ threonine protein kinase. One of the common clinical features of DM1 patients is insulin resistance, which has been associated with a pathogenic effect of the repeat expansions. Here we show that DMPK itself is a positive modulator of insulin action. DMPK-deficient (dmpk-/-) mice exhibit impaired insulin signaling in muscle tissues but not in adipocytes and liver, tissues in which DMPK is not expressed. Dmpk-/- mice display metabolic derangements such as abnormal glucose tolerance, reduced glucose uptake and impaired insulin-dependent GLUT4 trafficking in muscle. Using DMPK mutants, we show that DMPK is required for a correct intracellular trafficking of insulin and IGF-1 receptors, providing a mechanism to explain the molecular and metabolic phenotype of dmpk-/- mice. Taken together, these findings indicate that reduced DMPK expression may directly influence the onset of insulin-resistance in DM1 patients and point to dmpk as a new candidate gene for susceptibility to type 2-diabetes.

Original languageEnglish
Article numbere1134
JournalPLoS One
Volume2
Issue number11
DOIs
Publication statusPublished - Nov 7 2007

Fingerprint

protein kinases
Muscle
homeostasis
Homeostasis
insulin
Insulin
Glucose
Muscles
muscles
glucose
insulin resistance
Insulin Resistance
mice
Myotonic Dystrophy
IGF Type 1 Receptor
Protein-Serine-Threonine Kinases
glucose tolerance
Genes
adipocytes
muscle tissues

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Llagostera, E., Catalucci, D., Marti, L., Liesa, M., Camps, M., Ciaraldi, T. P., ... Kaliman, P. (2007). Role of myotonic dystrophy protein kinase (DMPK) in glucose homeostasis and muscle insulin action. PLoS One, 2(11), [e1134]. https://doi.org/10.1371/journal.pone.0001134

Role of myotonic dystrophy protein kinase (DMPK) in glucose homeostasis and muscle insulin action. / Llagostera, Esther; Catalucci, Daniele; Marti, Luc; Liesa, Marc; Camps, Marta; Ciaraldi, Theodore P.; Kondo, Richard; Reddy, Sita; Dillmann, Wolfgang H.; Palacin, Manuel; Zorzano, Antonio; Ruiz-Lozano, Pilar; Gomis, Ramon; Kaliman, Perla.

In: PLoS One, Vol. 2, No. 11, e1134, 07.11.2007.

Research output: Contribution to journalArticle

Llagostera, E, Catalucci, D, Marti, L, Liesa, M, Camps, M, Ciaraldi, TP, Kondo, R, Reddy, S, Dillmann, WH, Palacin, M, Zorzano, A, Ruiz-Lozano, P, Gomis, R & Kaliman, P 2007, 'Role of myotonic dystrophy protein kinase (DMPK) in glucose homeostasis and muscle insulin action', PLoS One, vol. 2, no. 11, e1134. https://doi.org/10.1371/journal.pone.0001134
Llagostera, Esther ; Catalucci, Daniele ; Marti, Luc ; Liesa, Marc ; Camps, Marta ; Ciaraldi, Theodore P. ; Kondo, Richard ; Reddy, Sita ; Dillmann, Wolfgang H. ; Palacin, Manuel ; Zorzano, Antonio ; Ruiz-Lozano, Pilar ; Gomis, Ramon ; Kaliman, Perla. / Role of myotonic dystrophy protein kinase (DMPK) in glucose homeostasis and muscle insulin action. In: PLoS One. 2007 ; Vol. 2, No. 11.
@article{fc06e6d832d342a6a98dfc05c6eba90e,
title = "Role of myotonic dystrophy protein kinase (DMPK) in glucose homeostasis and muscle insulin action",
abstract = "Myotonic dystrophy 1 (DM1) is caused by a CTG expansion in the 3′-unstranslated region of the DMPK gene, which encodes a serine/ threonine protein kinase. One of the common clinical features of DM1 patients is insulin resistance, which has been associated with a pathogenic effect of the repeat expansions. Here we show that DMPK itself is a positive modulator of insulin action. DMPK-deficient (dmpk-/-) mice exhibit impaired insulin signaling in muscle tissues but not in adipocytes and liver, tissues in which DMPK is not expressed. Dmpk-/- mice display metabolic derangements such as abnormal glucose tolerance, reduced glucose uptake and impaired insulin-dependent GLUT4 trafficking in muscle. Using DMPK mutants, we show that DMPK is required for a correct intracellular trafficking of insulin and IGF-1 receptors, providing a mechanism to explain the molecular and metabolic phenotype of dmpk-/- mice. Taken together, these findings indicate that reduced DMPK expression may directly influence the onset of insulin-resistance in DM1 patients and point to dmpk as a new candidate gene for susceptibility to type 2-diabetes.",
author = "Esther Llagostera and Daniele Catalucci and Luc Marti and Marc Liesa and Marta Camps and Ciaraldi, {Theodore P.} and Richard Kondo and Sita Reddy and Dillmann, {Wolfgang H.} and Manuel Palacin and Antonio Zorzano and Pilar Ruiz-Lozano and Ramon Gomis and Perla Kaliman",
year = "2007",
month = "11",
day = "7",
doi = "10.1371/journal.pone.0001134",
language = "English",
volume = "2",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "11",

}

TY - JOUR

T1 - Role of myotonic dystrophy protein kinase (DMPK) in glucose homeostasis and muscle insulin action

AU - Llagostera, Esther

AU - Catalucci, Daniele

AU - Marti, Luc

AU - Liesa, Marc

AU - Camps, Marta

AU - Ciaraldi, Theodore P.

AU - Kondo, Richard

AU - Reddy, Sita

AU - Dillmann, Wolfgang H.

AU - Palacin, Manuel

AU - Zorzano, Antonio

AU - Ruiz-Lozano, Pilar

AU - Gomis, Ramon

AU - Kaliman, Perla

PY - 2007/11/7

Y1 - 2007/11/7

N2 - Myotonic dystrophy 1 (DM1) is caused by a CTG expansion in the 3′-unstranslated region of the DMPK gene, which encodes a serine/ threonine protein kinase. One of the common clinical features of DM1 patients is insulin resistance, which has been associated with a pathogenic effect of the repeat expansions. Here we show that DMPK itself is a positive modulator of insulin action. DMPK-deficient (dmpk-/-) mice exhibit impaired insulin signaling in muscle tissues but not in adipocytes and liver, tissues in which DMPK is not expressed. Dmpk-/- mice display metabolic derangements such as abnormal glucose tolerance, reduced glucose uptake and impaired insulin-dependent GLUT4 trafficking in muscle. Using DMPK mutants, we show that DMPK is required for a correct intracellular trafficking of insulin and IGF-1 receptors, providing a mechanism to explain the molecular and metabolic phenotype of dmpk-/- mice. Taken together, these findings indicate that reduced DMPK expression may directly influence the onset of insulin-resistance in DM1 patients and point to dmpk as a new candidate gene for susceptibility to type 2-diabetes.

AB - Myotonic dystrophy 1 (DM1) is caused by a CTG expansion in the 3′-unstranslated region of the DMPK gene, which encodes a serine/ threonine protein kinase. One of the common clinical features of DM1 patients is insulin resistance, which has been associated with a pathogenic effect of the repeat expansions. Here we show that DMPK itself is a positive modulator of insulin action. DMPK-deficient (dmpk-/-) mice exhibit impaired insulin signaling in muscle tissues but not in adipocytes and liver, tissues in which DMPK is not expressed. Dmpk-/- mice display metabolic derangements such as abnormal glucose tolerance, reduced glucose uptake and impaired insulin-dependent GLUT4 trafficking in muscle. Using DMPK mutants, we show that DMPK is required for a correct intracellular trafficking of insulin and IGF-1 receptors, providing a mechanism to explain the molecular and metabolic phenotype of dmpk-/- mice. Taken together, these findings indicate that reduced DMPK expression may directly influence the onset of insulin-resistance in DM1 patients and point to dmpk as a new candidate gene for susceptibility to type 2-diabetes.

UR - http://www.scopus.com/inward/record.url?scp=42649084007&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42649084007&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0001134

DO - 10.1371/journal.pone.0001134

M3 - Article

C2 - 17987120

AN - SCOPUS:42649084007

VL - 2

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 11

M1 - e1134

ER -